Davoodi-Semiromi A, Lanyon G W, Davidson R, Connor M J
Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, Florida 32610, USA.
Am J Med Genet. 2000 Nov 6;95(1):49-52. doi: 10.1002/1096-8628(20001106)95:1<49::aid-ajmg10>3.0.co;2-p.
Blood samples from 47 unselected patients with colorectal cancer were used as a source of hMSH2 mRNA. We identified three new hMSH2 aberrant mRNAs including: 1) IVS15 +5 G-->C resulting in exon 15 skipping from transcript; 2) an mRNA deletion of exons 2 to 6 inclusive; and 3) an mRNA deletion of exons 2 to 8 inclusive. In order to find out whether or not exon skipping is a natural consequence of alternative mRNA splicing, total RNA from 20 healthy individuals was converted to cDNA by reverse-transcriptase polymerase chain reaction, and our results show that none of the healthy individuals have the above aberrant mRNA. Our results also show that the presence of mutations in colorectal cancer cases, which do not fully meet the hereditary non-polyposis colon cancer criteria, would suggest that all familial cases should be investigated for germ line mutations in the mismatch repair genes.
47例未经选择的结直肠癌患者的血样被用作hMSH2 mRNA的来源。我们鉴定出三种新的hMSH2异常mRNA,包括:1)IVS15 +5 G→C,导致转录本中外显子15跳跃;2)外显子2至6(含)的mRNA缺失;3)外显子2至8(含)的mRNA缺失。为了确定外显子跳跃是否是可变mRNA剪接的自然结果,通过逆转录酶聚合酶链反应将20名健康个体的总RNA转化为cDNA,我们的结果表明,健康个体中均没有上述异常mRNA。我们的结果还表明,在不完全符合遗传性非息肉病性结直肠癌标准的结直肠癌病例中存在突变,这表明所有家族性病例都应调查错配修复基因中的种系突变。